New drug combo shows promise for High-Risk throat cancer patients

This study tested whether adding an extra chemotherapy drug (capecitabine) after standard treatment helps people with advanced nasopharyngeal cancer that is likely to spread. 294 patients received either standard chemoradiotherapy alone or standard treatment plus capecitabine. The goal was to see if the combination could delay the cancer from spreading to other parts of the body.